CSIMarket
 
Arisz Acquisition Corp   (ARIZ)
Other Ticker:  
 
    Sector  Financial    Industry Blank Checks
   Industry Blank Checks
   Sector  Financial
 
Price: $10.3300 $0.04 0.388%
Day's High: $10.33 Week Perf: 0.58 %
Day's Low: $ 10.33 30 Day Perf: 1.57 %
Volume (M): 0 52 Wk High: $ 10.33
Volume (M$): $ 1 52 Wk Avg: $9.98
Open: $10.33 52 Wk Low: $9.79



 Market Capitalization (Millions $) 71
 Shares Outstanding (Millions) 7
 Employees -
 Revenues (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Arisz Acquisition Corp


   Company Address: C/O MSQ Ventures New York 10017 NY
   Company Phone Number: 845-9945   Stock Exchange / Ticker: NASDAQ ARIZ
   ARIZ is expected to report next financial results on May 12, 2023.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
     
• View Complete Report
   



Chemomab Therapeutics Ltd

Between many businesses, the CMMB disclosed as well the fourth quarter of 2022 performance

The investors did not expect any adjustments at the business all over the earnings cycle of fiscal October to December 31 2022 at the company. But, shareholders observe CMMBs' operating loss which has been at $-8.642 millions, during the same period.

Eterna Therapeutics Inc

Eterna Therapeutics Inc announced operating shortfall of $-4.737 millions, in the fiscal span ending December 31 2022

The investors haven't assumed some modifications at the top-line during the the October to December 31 2022 reporting cycle at the Eterna Therapeutics Inc . But, shareholders observe the Major Pharmaceutical Preparations company's operating shortfall which was at $-4.737 millions, during the matching time.

Camtek Ltd

Camtek Ltd delivered notable October to December 31 2022 three months Sales and bottom-line advance , where Sales inched up by 19.005 % to $320.91 millions when compared with the prior year period, bottom-line were up by 23.88 % at $1.66 per share.

Exagen Inc

Exagen Inc reported that Sales went up modest, in the fourth quarter of 2022 earnings season

For the fiscal span closing December 31 2022 XGN increased a loss per share of $-0.83 per share compare to $-0.41 a year prior and surged loss from $-0.47 per share from the prior financial reporting period.

Sales grew moderately by 1.166 % to $12.84 millions from $12.69 millions in the similar financial reporting period a year prior and sequentially Sales deteriorated by -12.828 % from $14.73 millions.

Nexa Resources S A

NEXAs' bottom-line deteriorated, despite the Sales improvement in the most recent fiscal period, net profit per share plummeted by -56.98 % to $0.37 per share, while Sales increased respectably by 15.708 % to $3.03 billions, from the similar reporting period a year prior.






 

Arisz Acquisition 's Segments
 
 
• View Complete Report


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

STGW's Profile

Stock Price

STGW's Financials

Business Description

Fundamentals

Charts & Quotes

STGW's News

Suppliers

STGW's Competitors

Customers & Markets

Economic Indicators

STGW's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071